In conclusion, these results suggest that increasing METTL9 levels in osteoporotic mice can effectively mitigate osteoporosis progression, making METTL9 a potential target for the diagnosis and treatment of osteoporosis. This evidence concerns the gene METTL9 and osteoporosis.